David Penson Archive — Page 2 of 2

Dr. David Penson, identified by the supplied caption, stands with arms crossed in a white Vanderbilt medical coat in a clinic hallway. A partially visible sign points to the waiting room.
September 11, 2014

Penson to lead Department of Urologic Surgery

David Penson, M.D., the Paul V. Hamilton, M.D. and Virginia E. Howd Professor of Urologic Oncology, will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015.

A physician in a white coat speaks with a seated woman in a medical examination room. An exam table, medical equipment, and a partially visible poster appear in the background.
March 27, 2014

Grant bolsters patient-centered outcomes research

Patient-centered outcomes research is the focus of a $3.3 million, five-year, institutional K12 training grant awarded to Vanderbilt University Medical Center by the Agency for Healthcare Research and Quality (AHRQ).

Group portrait of university faculty and administrators standing together at an indoor event, with palm plants and a dark stage backdrop behind them.
January 24, 2014

Nine faculty honored with endowed chairs

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.

Dr. David Penson, a bald man in a white medical coat and red striped tie, stands with his arms crossed in a hospital corridor.
May 23, 2013

VU to lead prostate cancer treatment research effort

David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men.

Two male physicians in white Vanderbilt lab coats stand side by side in a hospital corridor.
January 30, 2013

Long-term effects of prostate therapies tracked

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

Daniel Barocas, M.D., stands with his arms crossed in a white lab coat in a urology clinic hallway; blurred clinic activity and equipment are visible behind him. A wall sign reads “CHECKOUT →.”
August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.